Regeneron-Alnylam-Sanofi RNAi partnerships: what does the future hold?

La Boétie 2012
Alnylam announced it is concluding the research and product option phase of a 2014 RNAi therapeutics alliance in rare genetic diseases with Sanofi. Credit: Sanofi.